PT - JOURNAL ARTICLE AU - Ariane de Jesus Lopes de Abreu AU - João Roberto Cavalcante AU - Letícia Wigg de Araújo Lagos AU - Rosângela Caetano AU - José Ueleres Braga TI - Systematic review and meta-analysis of yellow fever vaccine in elderly population AID - 10.1101/2022.03.23.22272849 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.23.22272849 4099 - http://medrxiv.org/content/early/2022/03/24/2022.03.23.22272849.short 4100 - http://medrxiv.org/content/early/2022/03/24/2022.03.23.22272849.full AB - We conducted a systematic review and meta-analysis to assess the risk of serious adverse events in the elderly after yellow fever vaccination compared to the non-elderly population. We searched multiple databases and grey literature and selected research without language and publication date restriction. Studies were analysed in a descriptive way, meta-analysed and expressed in terms of prevalence ratio and risk ratio with a 95% confidence interval, depending on the degree of heterogeneity found. A total of 18 studies were included, of which 10 were meta-analysed. Results obtained through the meta-analysis showed that the risk of serious adverse events after yellow fever vaccination is three times higher for elderlies when compared to non-elderly population and even five times higher for persons >70 years of age. Also, in relation adverse event type a greater risk was for viscerotropic disease associated with yellow fever vaccine up to six times higher when compared to the population under 60 years. The evidence found in this review supports that the vaccine indication in individuals over 60 years of age should be based on a careful analysis of the individual benefit-risk assessment. Results found suggest a higher risk of SAE for individuals over 70 years, especially for viscerotropic and neurotropic disease associated with YFV contraindicating the use of the YFV in this age group.Competing Interest StatementThe authors have declared that no competing interests exist.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is a systematic literature review. Following the declaration of Helsinki and local guidelines no IRB approval is required for this study method.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableAll relevant data are within the manuscript and its Supporting Information files.